stars 1 stars 2 stars 3

AroCell AB is a Swedish company that develops and markets blood and urine sample tests. The corporation specializes in oncology and bacteriology. The company has a broad product portfolio, used in healthcare, and established in various markets. In oncology, AroCell uses various biomarkers, TK1, and cytokeratins, to support the treatment of various cancers such as breast, prostate, and bladder cancers. AroCell's product portfolio also includes a rapid bacteriological test for a simple and safe diagnosis of typhoid fever. AroCell (AROC) is listed on Nasdaq First North Growth Market with Redeye AB as Certified Adviser.

AroCell AB (AROC) Questions

The AroCell AB (AROC) annual revenue was $6.2 million in 2026.

Michael Brobjer is the Cheif Commercial Officer of AroCell AB (AROC).

1 people are employed at AroCell AB (AROC).

The NAICS codes for AroCell AB (AROC) are [3254, 32, 325, 325413, 32541].

The SIC codes for AroCell AB (AROC) are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users